SAMPLE. International Business Machines Corp. (IBM) BESPOKE DETAILED REVIEW. Provided for Client March 28, 2013
|
|
- Aleesha Green
- 5 years ago
- Views:
Transcription
1 BESPOKE DETAILED REVIEW International Business Machines Corp. (IBM) Provided for Client REVIEW CONTENTS: ANALYSTS: Key Takeaways Summary Quality of Revenue Quality of Earnings Quality of Cash Flow Corporate Governance Enitan Adebonojo, CFA, CPA
2 Key Takeaway Increase in receivables driven by financing offered to customers especially those considered below investment grade suggests IBM is having a more challenging time maintaining or growing its revenue base. Weak revenue growth despite acquisitions and little to no growth in backlog or deferred revenue suggests revenue growth will remain challenging. Earnings in the last three years have benefited from declines in depreciation expense. Earnings also benefited in the December 2012 quarter from a decline in the level of total allowance for doubtful accounts relative to total gross receivables. Summary SOURCE DOCUMENTS December K 5-years of financial data RELATED IRAP Computers & Peripherals CFRA SCORE QUALITY OF REVENUE P.3 Level of receivables has increased in the last five quarters, mostly due to an increase in the level of financing offered to customers. In addition, the percentage of financing going to customers rated as below investment grade has been rising. As such, IBM appears to be taking on more risk to maintain or grow revenues. Revenue growth appears weak despite benefit derived from acquisitions. IBM does not disclose the impact of acquisition on revenues. Trends in backlog and deferred revenue do not point to future revenue growth acceleration. QUALITY OF EARNINGS P.7 Depreciation expense has declined in the last three years, which has benefited earnings. In some periods, declines coincided with an increase in average gross PP&E. Earnings benefited in the December 2012 quarter from decline in the level of total allowance for doubtful accounts relative to total gross receivables. If provisions are inadequate, it may lead to higher charges in the future. Inventory level declined in December following an increase in prior periods. Current level is not concerning. Trends in research, development and engineering expense, prepaid expense and other current assets and other accrued expense and liabilities do not raise concern regarding possible earnings benefit. QUALITY OF CASH FLOW/LIQUIDITY P.9 Both trailing-twelve-month (TTM) cash flow from operations (CFFO) and free cash flow (FCF) remained positive but are off from their peak. We found no evidence of cash flow boost or manipulation. There appears to be no risk of a near-term liquidity event given current cash balance, cash flow generation and available credit facility versus current debt. CORPORATE GOVERNANCE P.10 IBM reported certain related party transactions, which typically raise concern that such transactions may not have been negotiated at arm s length. There have been no changes in auditor since at least fiscal Cash Flow Score: 3 rd Decile Earnings Score: 2 nd Decile 2
3 Quality of Revenue RECEIVABLES INCREASED IN THE LAST FIVE QUARTERS MOSTLY DUE TO INCREASED FINANCING IBM s revenue growth may have benefited in the last four quarters from an increase in the level of accounts receivable mostly driven by higher level of financing offered by the Company. It also appears that IBM is financing more sales to customers that have below investment credit rating which increases the risk of its financing operations and could lead to greater losses in the future. As shown on Table 1a, total notes, accounts and financing receivables measured in days (DSO) are at the highest level for the December quarter in five years, mostly due to an increase in financing receivables. Specifically, total DSO amounted to 135 days as of December 2012 versus a range of 122 to 125 days in each of the prior three December periods, and versus 131 days at December 2008, the height of the financial crisis. Similarly, DSO-Total Financing Receivables rose to 96 days as of December 2012, the highest level in the last five December quarters and in the last fifteen quarters. A larger proportion of financing appears has been going to customers that are ranked as below investment grade, which suggests that IBM may be taking on more risk to grow revenues. Total leases and loans receivable due from below investment grade customers rose to the highest level in at least nine quarters 38.5% as of December 2012 from 33.6% in the prior year and 30.1% two years prior. (See Table 1b.) As the Company continues to increase this pool of financing, the collection risk may increase, but some of the risk is likely mitigated by the fact that IBM can repossess leased equipment if a customer no longer meets its obligation. CFRA notes however that some of the financing offered by IBM may be supporting service revenue, as total origination in the last four years has exceeded total revenue from sales. (See Table 1c.) If correct, then some of the collection risk cannot be mitigated by IBM s ability to repossess items sold if some of the below investment grade financing receivables are related to service revenues. We have no reason to believe that any service revenue relates to sale of products. According to the K filing, services primarily include: information technology (IT) datacenter and business process outsourcing, application management services, consulting and systems integration, technology infrastructure and system maintenance, Web hosting and the design and development of complex IT systems to a client s specifications (design and build). Despite the increase in sales to lower credit rated customers, IBM does not appear to have suffered significant losses from non performing loans. To the extent that only sales of products are financed for these customers, risk of loss may be mitigated by IBM s ability to repossess equipment from customers that no longer meet their obligations. However, further growth in revenues from such customers may be limited. 3
4 Table 1a: Accounts and Financing Receivable Increased in the Last Four Quarters Q2, Q2, $ Mils. ex DSO in days Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Sep-10 Notes & Accounts Rec. 10,667 9,772 10,172 10,012 11,179 9,719 10,539 10,148 10,834 9,717 ST Financing Rec. 18,038 14,925 14,982 15,160 16,901 14,145 14,715 14,365 16,257 13,592 Other Receivables 1,873 2,066 1,703 1,669 1,481 1,123 1,127 1,145 1,134 1,187 Total Current Rec. 30,578 26,763 26,857 26,841 29,561 24,987 26,381 25,658 28,225 24,496 LT Financing Rec. 12,812 10,791 10,795 10,549 10,776 9,830 10,422 10,254 10,548 9,448 Total Receivables 43,390 37,554 37,652 37,390 40,337 34,817 36,803 35,912 38,773 33,944 Total Financing Rec. 30,850 25,716 25,777 25,709 27,677 23,975 25,137 24,619 26,805 23,040 Total Revenues 29,304 24,747 25,783 24,673 29,486 26,157 26,666 24,607 29,018 24,271 DSO Notes & Acct. Rec ST Financing Rec Other Receivables DSO Total Current Rec LT Financing Rec DSO Total Current & LT DSO Total Financing Rec YoY Change Total Current Rec (5) (0) 1 (1) 1 YoY Change Total Rec (6) 0 1 (4) (3) YoY Change Total Financing Rec (3) (0) 1 (1) (3) Table 1b: Leases and Loans Receivable Below Grade Relative to Total Q2, $ mil, ex % Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Q2, Jun-11 Total Leases & Loans Rec. 22,512 19,793 25,683 19,506 20,058 18,407 19,393 19,206 19,626 Amounts below Investment Grade 1 8,657 7,415 7,173 7,015 6,748 5,961 6,134 5,920 5,907 Amounts below Investment Grade 38.5% 37.5% 36.4% 36.0% 33.6% 32.4% 31.6% 30.8% 30.1% / Total Leases & Loans Receivable 1. These receivables are due from customers that have a credit rating of Ba1 or lower, as reported by IBM in its filings. Table 1c: Leases and Loans Receivable Below Grade Relative to Total Leases & Loans Receivable FY, FY, FY, FY, $ mil, ex % Dec-12 Dec-11 Dec-09 Annual Sales 43,014 44,063 40,736 38,300 Originations 53,222 49,673 45,113 39,641 Annual Sales as % of Originations 123.7% 112.7% 110.7% 103.5% 4
5 REVENUE GROWTH FOR 2012 APPEARS WEAK, DESPITE LIKELY BENEFITS FROM ACQUISITIONS IBM s revenue growth excluding the impact of foreign currency has been weak in the last four quarters, despite numerous acquisitions made in the last few years. (See Table 2.) Growth in prior periods likely benefited from acquisitions, but IBM does not quantify the impact of these acquisitions on its revenues even though it includes disclosure of the impact of acquisitions on total expenses i.e. acquisitions increased total expense by 3%. Anecdotal disclosure of acquisition impact on IBM s businesses per the latest 10-K filing included the following: In addition to organic investments, acquisitions have provided additional capabilities, while leveraging the existing portfolio of offerings. The software business completed nine acquisitions in 2012, further increasing the company s capabilities in analytics, cloud and Smarter Planet. The company further strengthened its WebSphere portfolio during the year with the acquisitions of Worklight, DemandTec, Emptoris and Tealeaf. The acquisitions of Varicent and Vivisimo expanded the Business Analytics and Optimization software capabilities. Tivoli security revenue increased 8 percent (10 percent adjusted for currency), with strong contribution from Q1 Labs which provides next generation security intelligence. Lotus revenue decreased 2.1 percent as reported, but was flat year to year at constant currency in The social business offerings performed well, including contribution from the acquisition of Kenexa, a leading provider of recruiting and talent management solutions. So while IBM clearly indicates that acquisitions have a beneficial impact on revenues, it does not quantify the impact or disclose organic revenue growth. Q1 Labs was acquired during the December 2011 quarter and reportedly was the growth driver for a 16% increase in Tivoli revenues during fiscal While revenues from Q1 Labs in the December 2012 may have been organic, this acquisition has not anniversaried in the first three quarters of Revenues also benefited during the December 2012 quarter from the acquisition of Kenexa Corporation, which closed December 2, Based on prior filings of the Company and the assumption that revenue growth in the December 2012 quarter remained flat relative to the September quarter (19.9%), CFRA estimates that this acquisition contributed approximately $31.2 million to revenues in December This acquisition alone contributed 10bps to the December 2012 growth rate. Other acquisitions made by IBM during 2012 and 2011 were privately held companies, and as such we are unable to estimate the impact those had on IBM s growth rate. Table 2: Revenue Growth Appears Weak in 2012 Q2, % Dec-12 Sep-12 Jun-12 YoY Revenue Growth Mar-12 Dec-11 Sep-11 Q2, Jun-11 Sep-10 Services (2.0%) (4.4%) (2.7%) 0.8% 2.8% 7.9% 10.3% 6.5% 2.7% 2.7% Sales 1.0% (6.7%) (4.3%) (0.3%) 1.0% 8.1% 16.5% 10.3% 11.6% 3.7% Financing (2.5%) (9.1%) (0.6%) (5.2%) (12.7%) (1.7%) (4.4%) (3.9%) 1.1% (1.5%) Total YoY Revenue Growth (.6%) (5.4%) (3.3%) 0.3% 1.6% 7.8% 12.4% 7.7% 6.6% 3.0% Total Growth, Ex FX Impact 0.30% (1.8%) 0.5% 1.0% 1.4% 2.7% 5.1% 5.0% 3.3% 3.6% 5
6 TREND IN BACKLOG AND DEFERRED REVENUE DO NOT POINT TO FUTURE GROWTH ACCELERATION IBM s backlog declined slightly in nominal terms from the prior year level following another decline in the prior year. However, as reported by the Company excluding the impact of currency backlog grew year-over-year by 0.6% and was up sequentially by 1.9% in December 2012 quarter. In general even focusing on growth adjusted for currency as reported by IBM, CFRA notes that growth in prior December periods were higher. (See Table 3a.) Currently, full year revenues are expected to growth by 1.7% to $ billion in 2013 despite the fact that approximately 70% of revenues come through backlog and there has been little to no growth in backlog. It is possible that IBM can continue acquiring other businesses in the near term to boost overall growth but it may not be sufficient. The current portion of deferred income measured in days fell slightly to 37 days from 38 days in the prior year but increase from 36 days two years ago. (See Table 3b.) Although this minimal decline may not pressure future revenue growth, deferred revenue likely will not drive future revenue growth either. Deferred income primarily consists of prepayments for service revenues ($7,281 million at December 2012) and to a limited extent payments for extended warranty contracts. There is limited disclosure regarding this account balance in IBM s filings. Table 3a: Trend in Backlog & Backlog Growth does not Point to Acceleration in Future Revenue Growth Q2, Q2, In millions, ex % Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Sep-10 Dec-12 Backlog 140, , , , , , , , , ,500 YoY Change Adj. for Currency 0.6% 1.3% 0.5% 0.7% 0.0% 2.3% 1.9% 1.5% 2.9% 0.4% Sequential Change Adj. for Currency 1.9% 1.1% (2.4%) (0.9%) 2.8% (5.1%) 0.0% 5.9% 3.9% Table 3b: Current Deferred Revenue Slightly Down in December 2012 $ Mils. ex DSDR in days Q2, Q2, Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Sep-10 Deferred Income - Current 11,952 11,230 12,311 13,269 12,197 11,252 12,660 12,820 11,580 10,499 Deferred Income - LT 4,491 4,263 3,889 3,904 3,847 3,634 3,641 3,724 3,666 3,487 Total Deferred Income 16,443 15,493 16,200 17,173 16,044 14,886 16,301 16,544 15,246 13,986 Total Revenue 29,304 24,747 25,783 24,673 29,486 26,157 26,666 24,607 29,018 24,271 DSDR Current DSDR - LT DSDR - Total
7 Quality of Earnings POSSIBLE EARNINGS BENEFIT FROM LOWER DEPRECIATION RATE IBM s earnings appear to have benefited in the last three years from declines in its depreciation expense and depreciation rate, which coincided in some periods with an increase in average gross property, plant and equipment (PP&E). However, we noted no changes in the Company s depreciation policy that would account for this decline. As shown on Table 4, depreciation expense fell to the lowest level in both nominal and relative terms in the December 2012 quarter - $820 million versus $888 million in the prior year. However, average gross PP&E increased to $40,608.5 million in December 2012 from $40,131.5 million in the prior year. Depreciation expense declined from the prior year level by $197 million in 2012, $68 million in 2011 and $116 million in Absent these declines annual EPS would have been $0.13 lower in fiscal 2012, $0.04 lower in 2011 and $0.07 lower in It is possible that some of this decline may be due to fully depreciated assets that have remained in operation, which could lead to higher expense in the future as these assets are replaced. Alternatively, the decline may also be due to replaced assets having longer lives (which may be within the stated policy) relative to assets that have been removed from service. Table 4: Decline in Depreciation Expense Appears Persistent In millions, ex % Q2, Q2, Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Sep-10 Depreciation Exp Ave. Gross PP&E 40, , , , , , , , , ,114.0 Depr. Exp. / Ave Gross PP&E 2.0% 2.1% 2.1% 2.1% 2.2% 2.2% 2.2% 2.3% 2.3% 2.3% POSSIBLE EARNINGS BENEFIT FROM LOWER ALLOWANCE FOR DOUBTFUL ACCOUNTS IBM s earnings may also have benefited in the last three years from declines in the level of total allowance for doubtful accounts (ADA) relative total gross receivables (GAR). The latest decline occurred in the December 2012 quarter as total ADA relative to total GAR fell to 1.8% from 1.9% in the prior year and 2.0% in the September 2012 quarter. Had ADA remained at the prior year level earnings would have been $0.02 lower in December 2012 quarter. Given the increase in financing receivables which accounts for the latest decline in total ADA, if current ADA level is not adequate, it may lead to higher charges in the future. Table 5: Allowance for Doubtful Accounts Declined Year-over-Year in Six Quarters Q2, Q2, % Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Sep-10 ADA / GAR Notes & Accts Rec. 2.3% 2.5% 2.5% 2.6% 2.2% 2.8% 2.8% 3.1% 2.9% 3.2% ADA / GAR ST Financing Rec. 1.6% 1.8% 1.8% 1.8% 1.8% 1.8% 1.9% 2.2% 2.1% 2.7% ADA / GAR Other Receivables 0.9% 1.0% 0.6% 0.5% 0.7% 1.0% 1.1% 1.0% 0.9% 0.8% Total ADA / Total GAR 1.8% 2.0% 2.0% 2.1% 1.9% 2.2% 2.2% 2.5% 2.3% 2.8% 7
8 INVENTORY NOT CONCERNING IBM s total and finished goods inventory declined slightly in the December 2012 quarter following increase in the prior four quarters and therefore does not raise concern regarding possible margin pressure that can arise from excess inventory. Specifically, total and finished goods (FG) inventory measured in days (DSI) amounted to 53 days and 11 days, respectively as of December This follows a year-over-year increases of 3 days to 10 day for total inventory and 2 to 6 days in finished goods in the prior four quarters. Given the decline we have no reason to raise concern. Table 6: Inventory Remained within Historical Range Q2, Days Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Q2, Jun-11 DSI Total YoY Change (2) (0) (8) (3) (4) 0 DSI - FG YoY Change (1) (1) (3) (1) Sep-10 TRENDS IN OTHER ACCOUNTS NOT CONCERNING Based on our analysis of accounts including but not limited to research, development and engineering (RD&E), prepaid expense and other current assets as well as other accrued expense and liabilities, we see no reason to raise concern regarding possible earnings boosts. (See Table 7.) RD&E expense increased slightly in the December 2012 quarter, following a decline in the prior year. However, this expense has been in a 5.3% to 6.8% range in the last fifteen quarters, so current level is closer to the lower end of the range. Significant declines in RD&E expense would raise concern regarding earnings boost or slower future revenue growth due to lack of investments. Prepaid expense & other current assets (OCA) as a percentage of revenues has been trending downward. Typically we would be concerned by increases that could suggest higher cost capitalization. Other accrued expense and liabilities as a percentage of revenues increased year-over-year in the last two quarters. Typically, we are concerned by significant declines that may suggest that expenses are not being accrued at historical levels, thereby benefiting earnings in the short-term. Table 7: Other Account Trends Q2, Q2, % Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Sep-10 RD&E / Sales & Software Rev. 5.5% 6.3% 6.3% 6.6% 5.4% 6.0% 6.0% 6.6% 5.6% 6.2% Prepaid Exp. & OCA / Revs. 13.7% 20.3% 19.8% 21.5% 17.8% 19.8% 17.5% 17.8% 14.6% 19.2% Other Accrued Exp. & Liabilities. / Revenues 16.5% 20.1% 17.8% 19.0% 15.4% 16.9% 19.3% 21.7% 17.8% 19.6% 8
9 Quality of Cash Flow / Liquidity TREND IN OPERATING CASH FLOW AND FREE CASH FLOW NOT CONCERNING There is no evidence of cash flow manipulation or unsustainable boosts, however, both trailing-twelve-month (TTM) cash flow from operations (CFFO) and TTM free cash flow (FCF) are off from their peak. In addition, there appears to be no risk of near term liquidity risk given cash balance of $10.4 billion adjusted TTM FCF generate of at least $9.6 billion in the last 10 quarters versus current debt of just $9.2 billion as of December IBM also has an untapped $10.0 billion credit facility. Table 8: TTM Operating Cash Flow and TTM Free Cash Flow off from Peak Levels Q2, Q2, $ millions Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Sep-10 CFFO 6,345 4,514 4,435 4,291 7,097 4,679 4,279 3,792 6,795 4,551 TTM CFFO 19,585 20,337 20,502 20,346 19,847 19,545 19,417 18,904 19,549 19,203 TTM FCF 15,278 15,954 16,173 16,343 15,788 15,441 15,296 14,766 15,565 15,172 Adjusted TTM FCF 1 11,556 12,100 12,596 13,264 13,977 12,289 10,224 9,617 9,643 11,110 Current Debt 9,181 9,334 7,669 6,293 8,463 6,071 7,858 8,508 6,778 5,556 Total Debt 33,269 33,667 32,435 32,053 31,320 30,160 29,773 30,257 28,624 27, TTM adjusted for the cash outflow related to acquisitions 9
10 Corporate Governance RELATED PARTY TRANSACTIONS In regards to certain transactions and relationships, IBM included the following disclosure in its latest proxy filing: In connection with Mr. Palmisano s retirement from the Company effective December 1, 2012, the Board approved certain a post-retirement consulting arrangement whereby he may be asked from time to time to provide services as an independent contractor. The fee for such services would be $20,000 per day for each day he provides four or more hours of services and $10,000 per day for each day he provides less than four hours. As of December 2012 no consulting fees have been paid to Mr. Palmisano. From time to time, the Company may have employees who are related to our executive officers or directors. As noted in the discussion above on General Information Board of Directors, Mr. Eskew s son is employed by the Company. He is an executive of the Company (not an executive officer). In addition, an adult child of Mr. M. E. Daniels (Senior Vice President and Group Executive, Services) and a sibling of Dr. J.E. Kelly III (Senior Vice President and Director, Research) are employed by the Company in non-executive positions. Further, a brother-in-law of Mr. M. Loughridge (Senior Vice President and Chief Financial Officer, Finance and Enterprise Transformation) and the spouse of Mr. T.S. Shaughnessy (Senior Vice President, GTS Services Delivery) are executives of the Company. None of the above-referenced family member employees are executive officers of IBM. Each employee mentioned above received compensation in 2012 between $120,000 and $500,000. Additionally, in 2012 the above-referenced family members of Messrs. Eskew, Daniels, Loughridge and Shaughnessy each received an equity grant. The compensation and other terms of employment of each of the family member employees noted above are determined on a basis consistent with the Company s human resources policies. CFRA is typically concerned that the terms of transactions with related persons may not have been negotiated at arm s length. 10
11 Client Services + 1 (212) cservices@cfraresearch.com CFRA research is delivered by Institutional Shareholder Services Inc. ( ISS ). ISS is an indirect wholly-owned subsidiary of MSCI Inc. ( MSCI ). MSCI is a publicly traded company on the NYSE (Ticker: MSCI). As such, MSCI is not generally aware of who its stockholders are at any given point in time. ISS has, however, established policies and procedures to restrict the involvement of any of MSCI s non-employee stockholders, their affiliates and board members in the content of ISS analyses. Neither MSCI s non-employee stockholders, their affiliates, nor MSCI s non-management board members are informed of the contents of any of ISS analyses prior to their publication or dissemination. The issuer that is the subject of this analysis may be a client of CFRA, ISS, ICS, or another MSCI subsidiary, or the parent of, or affiliated with, a client of CFRA, ISS, ICS, or another MSCI subsidiary. CFRA s financial data provider for financial companies is SNL FINANCIAL LC. CONTAINS COPYRIGHTED AND TRADE SECRET MATERIAL DISTRIBUTED UNDER LICENSE FROM SNL. FOR RECIPIENT S INTERNAL USE ONLY The content of this report and the opinions expressed within are those of the CFRA research team and not of any other employee or MSCI entity, including ISS or ICS. This analysis has not been submitted to, nor received approval from, the United States Securities and Exchange Commission or any other regulatory body. While ISS exercised due care in compiling this analysis, it makes no warranty, express or implied, regarding the accuracy, completeness or usefulness of this information and assumes no liability with respect to the consequences of relying on this information for investment or other purposes. In particular, the research provided is not intended to constitute an offer, solicitation or advice to buy or sell securities. This issuer may have purchased self-assessment tools and publications from ISS Corporate Services, Inc. ("ICS"), a wholly-owned subsidiary of Institutional Shareholder Services Inc. ("ISS"), or ICS may have provided advisory or analytical services to the issuer in connection with the proxies described in this report. No employee of ICS played a role in the preparation of this report. If you are an ISS institutional client, you may inquire about any issuer's use of products and services from ICS by ing cfra_disclosure@msci.com. ISS, ICS, MSCI, M&A Edge, CFRA, CFRA Accounting Lens, CFRA Legal Edge and all other ISS product names are the trademarks, registered trademarks, or service marks of ISS or its affiliates in the United States and other jurisdictions. 11
SolarCity Corporation (SCTY)
SolarCity Corporation (SCTY) BESPOKE DETAILED REVIEW Provided for Client REVIEW CONTENTS: ANALYST: Key Takeaways Summary Quality of Revenue Quality of Earnings Quality of Cash Flow Corporate Governance
More informationSAMPLE. Company Risk Highlights. Financial Risks
CFRA COMPANY RISK DASHBOARD Leap Wireless International, Inc. (LEAP) Updated: December 8, 11 Company Risk Highlights CFRA s Risk Dashboard provides multiple views of a company s risk. Each risk metric
More informationIBM Reports 2009 Second-Quarter Results
ARMONK, NY - 16 Jul 2009: IBM Reports 2009 Second-Quarter Results Diluted earnings of $2.32 per share, up 18 percent; Raises full-year 2009 EPS expectations to at least $9.70 from $9.20; Free cash flow
More informationSAMPLE. Chinese Accounting Errors: An Analysis of Restatements. CFRA ACADEMY: Educational Report. Introduction
CFRA ACADEMY: Educational Report October 6, 2011 Chinese Accounting Errors: An Analysis of Restatements COMPANIES KEY TAKEAWAY The report analyzes the nature of accounting errors reported by US listed
More informationWe Raise Our Price Target To $4 (From $3); Think Strong Outlook For Revenue And EBITDA Growth Warrants Higher Valuation
July 13, 2018 Company Sponsored Research Morning Meeting Note Raise Price Target Sify Technologies Limited Sponsored ADR (SIFY) Equity Research We Raise Our Price Target To $4 (From $3); Think Strong Outlook
More information1Q 2011 Earnings Presentation April 19,
1Q 2011 Earnings Presentation April 19, 2011 Forward Looking Statements and Non-GAAP Information Certain comments made in this presentation may be characterized as forward looking under the Private Securities
More informationAnalysis of CFRA Earnings Score Model Performance
Phone: +1 212.981.1062 www.cfraresearch.com CFRA SCORE PERFORMANCE Analysis of CFRA Earnings Model Performance By Suraj Srinivasan, PhD September 4, 2013 CONTACT Dan Mahoney, CFA, CPA Phone: (646) 517-2417
More informationIBM REPORTS 2011 FIRST-QUARTER RESULTS
IBM REPORTS 2011 FIRST-QUARTER RESULTS First-Quarter 2011: Diluted EPS: o GAAP: $2.31, up 17 percent; o Operating (non-gaap): $2.41, up 21 percent; Revenue: $24.6 billion, up 8 percent, up 5 percent adjusting
More informationPentair plc NEUTRAL ZACKS CONSENSUS ESTIMATES (PNR-NYSE)
March 20, 2015 Pentair plc (PNR-NYSE) Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 01/12/2014 Current Price (03/19/15) $64.38 Target Price $68.00 52-Week
More informationAllscripts Healthcare Solutions, Inc.
December 01, 2014 Allscripts Healthcare Solutions, Inc. Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Outperform Date of Last Change 05/17/2012 Current Price (11/28/14) $12.02 Target
More informationo Operating (non-gaap) Results, including workforce rebalancing charges:
IBM REPORTS 2013 SECOND-QUARTER RESULTS RAISES 2013 OPERATING EPS EXPECTATION BY $0.20 to $16.90, EXCLUDING $1 BILLION SECOND-QUARTER WORKFORCE REBALANCING CHARGE o GAAP Results: - Diluted EPS: $2.91,
More informationIBM REPORTS 2015 THIRD-QUARTER RESULTS
IBM REPORTS 2015 THIRD-QUARTER RESULTS o Diluted EPS from continuing operations: - Operating (non-gaap): $3.34, down 9 percent; - GAAP: $3.02, down 13 percent; o Net income from continuing operations:
More informationItron, Inc. UNDERPERFORM ZACKS CONSENSUS ESTIMATES (ITRI-NASDAQ) SUMMARY
February 13, 2015 Itron, Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 02/08/2015 Current Price (02/12/15) $35.87 Target Price $33.00 SUMMARY DATA UNDERPERFORM 52-Week High
More informationIBM REPORTS 2015 FIRST-QUARTER RESULTS
IBM REPORTS 2015 FIRST-QUARTER RESULTS o Diluted EPS from continuing operations: - Operating (non-gaap): $2.91, up 9 percent; - GAAP: $2.44, flat year-to-year; o Net income from continuing operations:
More informationIBM REPORTS 2014 THIRD-QUARTER RESULTS
IBM REPORTS 2014 THIRD-QUARTER RESULTS NOTE: Results from continuing operations exclude discontinued Microelectronics business, to be acquired by GLOBALFOUNDRIES as announced today. o Diluted EPS from
More informationAvery Dennison Corporation
March 20, 2015 Avery Dennison Corporation Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 09/26/2013 Current Price (03/19/15) $53.00 Target Price $56.00 SUMMARY DATA
More informationZacks Small-Cap Research
Zacks Small-Cap Research Sponsored Impartial - Comprehensive May 2, 2018 Lisa Thompson 312-265-9517 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 O2Micro International Ltd
More informationIndustry Overview February 16, 2010
Industry Overview February 16, 2010 Enterprise Software Brendan Barnicle 503.727.0624 bbarnicle@pacific-crest.com Matthew Coss 503.727.0622 mcoss@pacific-crest.com With Expectations Reset, Time to Add
More informationKingsoft (3888 HK) Buy (maintained) Target price: HK$ Strong earnings recovery ahead amid continued revenue momentum; maintain Buy
Equity Research Information Technology Mar 29, 216 Kingsoft (3888 HK) Buy (maintained) Target price: HK$24.7 Strong earnings recovery ahead amid continued revenue momentum; maintain Buy FY1 results in
More informationZacks Small-Cap Research
Zacks Small-Cap Research Sponsored Impartial - Comprehensive July 5, 2018 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Medical Transcription
More informationIBM REPORTS 2015 SECOND-QUARTER RESULTS
IBM REPORTS 2015 SECOND-QUARTER RESULTS Second-Quarter 2015: o Diluted EPS from continuing operations: - Operating (non-gaap): $3.84, down 13 percent; - GAAP: $3.58, down 15 percent year-to-year; o Net
More informationSmall-Cap Research (SILC-NASDAQ) SILC: Growth Eludes Silicom for the Next Few Quarters- Downgrading to Hold OUTLOOK SUMMARY DATA ZACKS ESTIMATES
Small-Cap Research July 23, 2014 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Silicom Limited (SILC-NASDAQ) SILC: Growth Eludes Silicom for the
More informationZacks Small-Cap Research
Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 1, 2018 Lisa Thompson 312-265-9517 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 O2Micro International Ltd
More informationXYLEM INC. Q EARNINGS RELEASE FEBRUARY 1, 2018
XYLEM INC. Q4 2017 EARNINGS RELEASE FEBRUARY 1, 2018 Q4 2017 EARNINGS RELEASE FORWARD-LOOKING STATEMENTS This presentation contains information that may constitute forward-looking statements. Forward-looking
More information1Q 2010 Earnings Presentation April 19,
1Q 2010 Earnings Presentation April 19, 2010 Forward Looking Statements Certain comments made in this presentation may be characterized as forward looking under the Private Securities Litigation Reform
More informationPitney Bowes Inc. (PBI-NYSE) Analyst Note
February 03, 2015 Pitney Bowes Inc. (PBI-NYSE) Analyst Note Current Recommendation Prior Recommendation Outperform Date of Last Change 05/01/2014 Current Price (02/02/15) $22.26 Target Price $23.00 NEUTRAL
More informationPlease see pages 8 and 9 of this publication for important certification and disclosure information.
Industry: Financial Services GICS Sector/ Sub code: Financials Sector / Banks (GIC Code: 40 / Sub code: 4010) Company Summary: Lending Club ( LC, or the Company) is the world s largest online marketplace
More informationZacks Small-Cap Research
Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 21, 2018 M. Marin 312-265-9211 mmarin@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Legacy Education Alliance, Inc.
More informationF I N A N C I A L R E S U L T S
J U L Y 1 8, 2 0 0 7 F I N A N C I A L R E S U L T S Second Quarter 2007 2Q07 Managed Results 1 $ in millions 1Q07 2Q Revenue (FTE) 1 $19,819 $78 $3,955 -- 25% Credit Costs 1 2,119 518 1,5 32% 101% Expense
More informationFourth-Quarter 2009 Earnings Presentation
Fourth-Quarter 2009 Earnings Presentation Ursula Burns Chief Executive Officer Larry Zimmerman Vice Chairman & CFO January 21, 2010 Forward-Looking Statements This presentation contains "forward-looking
More informationInternational Business Machines Corp.
Summary: International Business Machines Corp. Primary Credit Analyst: John D Moore, CFA, New York (1) 212-438-2140; john.moore@spglobal.com Secondary Contact: David T Tsui, CFA, CPA, New York (1) 212-438-2138;
More informationInteractive Brokers Group, Inc.
January 06, 2015 Interactive Brokers Group, Inc. (IBKR-NASDAQ) Current Recommendation NEUTRAL Prior Recommendation Outperform Date of Last Change 07/08/2014 Current Price (01/05/15) $28.88 Target Price
More informationQ Earnings. July 26, 2017
Q3 2017 Earnings July 26, 2017 Forward-Looking Statements and Non-GAAP Measures Forward-Looking Statements This presentation contains certain forward-looking statements within the meaning of the U.S. Private
More information(RHI-NYSE) SUMMARY. Risk Level *
March 04, 2015 Robert Half International Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/19/2012 Current Price (03/03/15) $62.70 Target Price $66.00
More informationNavigant Consulting Inc.
February 17, 2015 Navigant Consulting Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/15/2013 Current Price (02/16/15) $14.99 Target Price $16.00
More informationAnalyst's Notes. Argus Recommendations
Report created Jul 23, 2015 Page 1 OF 5 Boeing manufactures commercial jetliners and military aircraft as well as rotorcraft, electronic and defense systems, missiles, satellites, launch vehicles, and
More informationBank Default Risk Improves in 2017
FEBRUARY 5, 2018 CREDITEDGE RESEARCH TOPICS @CREDIT EDGE Moody s Credit Risk Analytics Group Authors: David W. Munves, CFA Managing Director 1.212.553.2844 david.munves@moodys.com Yukyung Choi Associate
More informationRelease Date Conference Call Time (Eastern) Contact Co. Guidance Consensus TBD TBD TBD TBD N/A $0.02
October 9, 2018 Company Sponsored Research Morning Meeting Note Earnings Preview Sify Technologies Limited Sponsored ADR (SIFY) Equity Research Expect 2Q:F19 EPS Will Be Flat Year Over Year On 15% Higher
More informationGenworth Financial Inc.
February 12, 2015 Genworth Financial Inc. Current Recommendation Prior Recommendation Neutral Date of Last Change 08/22/2014 Current Price (02/11/15) $8.33 Target Price $7.50 SUMMARY DATA UNDERPERFORM
More informationathenahealth Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (ATHN-NASDAQ) SUMMARY
February 10, 2015 athenahealth Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 10/23/2011 Current Price (02/09/15) $136.28 Target Price $143.00 52-Week
More information1Q 2014 Earnings Presentation
1Q 2014 Earnings Presentation April 16, 2014 www.ibm.com/investor Forward Looking Statements and Non-GAAP Information Certain comments made in this presentation may be characterized as forward looking
More informationInvestor Teleconference Presentation First Quarter Fastenal Company April 11, 2018
Investor Teleconference Presentation First Quarter 2018 Fastenal Company April 11, 2018 1 Safe Harbor Statement All statements made herein that are not historical facts (e.g., goals regarding Onsite and
More informationSmall-Cap Research. O2Micro International Ltd (OIIM-NASDAQ)
Small-Cap Research January 26, 2017 Lisa Thompson 312-265-9517 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 O2Micro International Ltd (OIIM-NASDAQ) Q4 Revenues Up 19% and
More informationS&P 500 Sector Intellect Trend Analysis Homebuilders
S&P 500 Sector Intellect Trend Analysis Homebuilders December 14, 2016 Lindsey Bell Senior Analyst lindsey.bell@spglobal.com Too Early To Break Ground On A Homebuilding Recovery Searching High and Low
More informationCullen/Frost Bankers, Inc.
December 26, 2014 Cullen/Frost Bankers, Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Neutral Date of Last Change 11/30/2001 Current Price (12/25/14) $70.74 Target Price $74.00
More informationEquity Research. Bank of the Ozarks, Inc. (OZRK-NSDQ) OUTLOOK SUMMARY DATA ZACKS ESTIMATES. Hold Prior Recommendation. Current Recommendation
Equity Research July 14, 2006 Scott A. Jaggers, CFA www.zacks.com 155 North Wacker Drive Chicago, IL 60606 Bank of the Ozarks, Inc. (OZRK-NSDQ) Current Recommendation Hold Prior Recommendation Sell Date
More informationLower Price Target To $4 (From $6); Near-Term Trends Are Less Favorable, But We Think Investment In Products Should Yield Benefits Over Time
April 27, 2018 Company Sponsored Research Morning Meeting Note Lower Price Target; Lower Earnings Estimates Socket Mobile, Inc. (SCKT) Equity Research Lower Price Target To $4 (From $6); Near-Term Trends
More informationKingsoft (3888 HK) Buy (maintained) Target price: HK$ Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$20.
Equity Research Information Technology Kingsoft (3888 HK) Buy (maintained) Target price: HK$2.77 2Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$2.77 2Q16 results in
More informationSmall-Cap Research. Chesapeake Financial Shares, Inc. (CPKF - OTCQB) OUTLOOK CPKF: Third Quarter Results Justify CPKF s Recent 7% Dividend Increase
Small-Cap Research November 25, 2015 Ann H. Heffron, CFA, CPA 312-265-9428 aheffron@zacks.com scr.zacks.com 111 North Canal Street Chicago, IL 60606 Chesapeake Financial Shares, Inc. (CPKF - OTCQB) OUTLOOK
More informationRelease Date Conference Call Time (Eastern) Contact Co. Guidance Consensus May 9 May 10 8:30am TBA NA $0.29
April 19, 2018 Company Sponsored Research Morning Meeting Note Earnings Preview OTC Markets Group Inc. (OTCM) Equity Research Forecast 10% EPS Growth In 1Q:18, Aided By Lower Taxes; View OTCM As Well Positioned
More informationKelly Services, Inc. First Quarter. May 11, 2017
Kelly Services, Inc. First Quarter May 11, 2017 Safe Harbor Statement This release contains statements that are forward looking in nature and, accordingly, are subject to risks and uncertainties. These
More information1Q 2008 Earnings Presentation April 16,
1Q 2008 Earnings Presentation April 16, 2008 Forward Looking Statements Certain comments made in this presentation may be characterized as forward looking under the Private Securities Litigation Reform
More informationLuk Fook (590 HK) Hold Target price: HK$ Downgrade to Hold on more challenging HK & Macau market outlook. Equity Research Consumer Discretionary
Equity Research Consumer Discretionary Luk Fook (590 HK) Hold Target price: HK$24.60 Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 1010 GF Securities (Hong Kong) Brokerage Limited
More informationAvnet, Inc. Reports Third Quarter Fiscal Year 2012 Results
Avnet, Inc. Reports Third Quarter Fiscal Year 2012 Results Progress at Both Operating Groups Consistent with Expectations PHOENIX--(BUSINESS WIRE)-- Avnet, Inc. (NYSE:AVT) today announced results for the
More informationTorchmark Corp. NEUTRAL ZACKS CONSENSUS ESTIMATES (TMK-NYSE) SUMMARY
March 12, 2015 Torchmark Corp. Current Recommendation NEUTRAL Prior Recommendation Underperform Date of Last Change 07/20/2006 Current Price (03/11/15) $53.41 Target Price $56.00 SUMMARY DATA (TMK-NYSE)
More informationSunGard Announces 2009 Results
For more information, contact: Robert Woods Eric Erickson Kris Block Tel: 484-582-5645 Tel: 484-582-5480 Tel: 484-582-5505 robert.woods@sungard.com eric.erickson@sungard.com kris.block@sungard.com SunGard
More informationDover Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (DOV-NYSE) SUMMARY
March 09, 2015 Dover Corporation Current Recommendation Prior Recommendation Outperform Date of Last Change 01/11/2011 Current Price (03/06/15) $70.71 Target Price $74.00 NEUTRAL SUMMARY (DOV-NYSE) In
More informationSyneos Health. Q Financial Results. August 2, 2018
Syneos Health Q2 2018 Financial Results August 2, 2018 Forward-Looking Statements, Non-GAAP Financial Measures, and Basis of Financial Presentation Forward-Looking Statements Except for historical information,
More informationRBC Midwest NDR NASDAQ: HEES. John Engquist CHIEF EXECUTIVE OFFICER Kevin Inda VICE PRESIDENT OF INVESTOR RELATIONS. Company Participants
Company Participants John Engquist CHIEF EXECUTIVE OFFICER Kevin Inda VICE PRESIDENT OF INVESTOR RELATIONS NASDAQ: HEES August 15-16, 2018 2 Legal Disclaimers Forward-Looking Information This presentation
More informationSMART STEEL. Q Results. Detlef Borghardt, CEO Dr. Matthias Heiden, CFO. November 8, 2018
SMART STEEL Q3 218 Results Detlef Borghardt, CEO Dr. Matthias Heiden, CFO November 8, 218 Agenda Business Summary Preliminaries confirmed Market update Segments: Status and profitability trend in the regions
More informationMSCI High Dividend Yield Indices Methodology
MSCI High Dividend Yield Indices Methodology 1. Introduction MSCI has created the MSCI High Dividend Yield Indices to serve as a performance benchmark for investors focusing on dividend yield and to help
More informationAdvanced Vision Techn Buy
16/9/13 16/11/13 16/1/14 16/3/14 16/5/14 16/7/14 16/9/14 16/11/14 16/1/15 16/3/15 16/5/15 16/7/15 MATELAN Research Update Note Closing price as of 13/8/15: 9.16 14 August 215 Company / Sector Fair Value
More informationZebra Technologies Announces Third-Quarter Results
Zebra Technologies Announces Third-Quarter Results Third-Quarter Financial Highlights Strong net sales of $1,092 million; year-over-year growth of 16.8% Net income of $127 million and net income per diluted
More informationWe Distribute Products That Deliver Energy to the World. NOW Inc., Second Quarter 2016 Review & Key Takeaways
We Distribute Products That Deliver Energy to the World NOW Inc., Second Quarter 2016 Review & Key Takeaways Forward Looking Statements Statements made in the course of this presentation that state the
More informationGFAMSA Retail. Quarterly Report July 29, GFAMSA Market Performer 12M FWD Price Target P$8.6
Quarterly Report GFAMSA Market Performer 12M FWD Price Target P$8.6 Price 7.8 12M Price Range 6.77 / 15.34 Shares Outstanding (Mill) 562 Market Cap (Mill) 4,383 Float 36% Net Debt (Mill) 27,728 EV (Mill)
More informationAsure Software, Inc. (NasdaqCM: ASUR)
Asure Software, Inc. (NasdaqCM: ASUR) July 13, 2012 Rating: Strong Buy Target Price: $19.15 Recent Price: $7.45 Analyst Specialist Thomas Pfister Jon Cunningham 800-733-2447 800-733-2447 Ext. 107 Thomas@redchip.com
More information1Q 2013 Earnings Presentation April 18,
1Q 2013 Earnings Presentation April 18, 2013 www.ibm.com/investor Forward Looking Statements and Non-GAAP Information Certain comments made in this presentation may be characterized as forward looking
More informationBank of America Merrill Lynch NDR - NYC
- NYC Company Participants Bank of America Merrill Lynch NDR - NYC John Engquist CHIEF EXECUTIVE OFFICER Brad Barber PRESIDENT AND CHIEF OPERATING OFFICER Kevin Inda VICE PRESIDENT OF INVESTOR RELATIONS
More informationKingsoft (3888 HK) Buy (maintained) Target price: HK$20.77
Equity Research Information Technology May 24, 216 Kingsoft (3888 HK) Buy (maintained) Target price: HK$2.77 Full-year earnings forecast trimmed as 1Q16 results miss; maintain Buy but lower target price
More informationTrimble Second Quarter 2018 Results Summary
Trimble Second Quarter 2018 Results Summary Forward-looking statements Certain statements made in this presentation and any subsequent Q&A period are forward-looking statements, within the meaning of Section
More informationEVRY ASA Q4/FY 2017 PRESENTATION. CEO Björn Ivroth CFO Henrik Schibler
EVRY ASA Q4/FY 2017 PRESENTATION CEO Björn Ivroth CFO Henrik Schibler Agenda Q4/ Preliminary FY 2017 presentation Group highlights Business update & trends Financial highlights Business area performance
More information2017 THIRD QUARTER RESULTS. Ended September 30, 2017
2017 THIRD QUARTER RESULTS Ended September 30, 2017 Forward Looking Statements Disclaimer This presentation contains statements, including statements about future plans and expectations, which constitute
More informationMGIC Investment Corporation
Upsi de 25.1% 09-Mar-2015, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A, N/A Equity Research October 15, 2015 Mark Palmer (212) 588-6582 mpalmer@btig.com Giuliano
More informationSUMMARY. Risk Level *
February 02, 2015 Xerox Corporation Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Underperform Date of Last Change 10/18/2012 Current Price (01/30/15) $13.17 Target Price $14.00 52-Week
More informationAvid Technology Q Business Update November 9, 2017
Avid Technology Q3 2017 Business Update November 9, 2017 1 Introduction Dean Ridlon Investor Relations 2 Non-GAAP & Operational Measures The following Non-GAAP (Adjusted) Measures & Operational Measures
More informationAvnet, Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (AVT-NYSE) SUMMARY
January 30, 2015 Avnet, Inc. Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Underperform Date of Last Change 04/02/2013 Current Price (01/29/15) $42.26 Target Price $44.00 52-Week High
More informationSmall-Cap Research. Chesapeake Financial Shares, Inc. (CPKF-OTC) OUTLOOK. CPKF: Spectacular Quarter with Diluted EPS Surging 32% Year over Year
Small-Cap Research June 15, 2017 Ann H. Heffron, CFA, CPA 312-265-9428 aheffron@zacks.com scr.zacks.com 10 South Riverside Plaza, Chicago, IL 60606 Chesapeake Financial Shares, Inc. (CPKF-OTC) CPKF: Spectacular
More informationQ Earnings Call. November 5, 2012
Q4 2012 Earnings Call November 5, 2012 Forward-Looking Statements and Non-GAAP Measures Forward-Looking Statements -- This presentation contains certain forward-looking statements within the meaning of
More informationMSCI. J.P. Morgan Global High Yield & Leveraged Finance Conference Kathleen Winters, CFO. February 28, 2017
MSCI J.P. Morgan Global High Yield & Leveraged Finance Conference Kathleen Winters, CFO February 28, 2017 2017 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document.
More informationQ3 Fiscal Year 2013 Earnings Conference Call
NASDAQ: CMCO Q3 Fiscal Year 2013 Earnings Conference Call January 25, 2013 Timothy T. Tevens President & Chief Executive Officer Gregory P. Rustowicz Vice President - Finance & Chief Financial Officer
More informationSmall-Cap Research. Chesapeake Financial Shares, Inc. (CPKF-OTC) OUTLOOK
Small-Cap Research February 22, 2017 Ann H. Heffron, CFA, CPA 312-265-9428 aheffron@zacks.com scr.zacks.com 10 South Riverside Plaza, Chicago, IL 60606 Chesapeake Financial Shares, Inc. (CPKF-OTC) CPKF:
More informationINTERNATIONAL BONDS. Original amount (USDm) 2020 Sr. Unsecured USD Jun NR / B / B- INDEBTEDNESS
INTERNATIONAL BONDS GRUPO FAMSA RETAIL Instrument Currency Coupon (%) Maturity Original (USDm) Amount outstanding (USDm) Price Yield (%) Z-spread (bps) Rating: M/S&P/F 22 Sr. Unsecured USD 7. 1-Jun-22
More informationSMART STEEL. Q Results. Detlef Borghardt, CEO Dr. Matthias Heiden, CFO. August 14, 2018
SMART STEEL Q2 218 Results Detlef Borghardt, CEO Dr. Matthias Heiden, CFO August 14, 218 Agenda Business Summary Guidance adjustment FY 218 Market update Regional trends: Status and profitability trend
More informationADP Reports Fourth Quarter and Fiscal 2018 Results; Provides Fiscal 2019 Outlook
ADP Reports Fourth Quarter and Fiscal 2018 Results; Provides Fiscal 2019 Outlook Revenues increased 8% to $13.3 billion for the year, 6% organic constant currency Worldwide new business bookings increased
More informationAnalyst's Notes. Argus Recommendations
Report created Jan 17, 2018 Page 1 OF 5 Citigroup is one of world's largest banks, with global consumer banking, corporate banking, and investment banking operations. Of the largest U.S. banks, Citigroup
More informationCOMPANY SNAPSHOT 08/26/2010 Last Closing Stock Price as of 08/25/2010: $10.22
Last Closing Stock Price as of 08/25/2010: $10.22 Company Snapshot This report presents a concise review of our DCF valuation and economic profitability analysis from our MaxVal model. Contributors Equity
More informationGlobal Blood Therapeutics Inc GBT
Global Blood Therapeutics Inc GBT Page 1 of 5 Last Close Fair Value Q Market Cap Industry of Domicile 29 Nov 217 3 Nov 217 2: UTC 29 Nov 217 37.4 36.84 1,634.4 Mil d Healthcare Biotechnology USA United
More informationCincinnati Financial Corp.
February 06, 2015 Cincinnati Financial Corp. NEUTRAL Current Recommendation Prior Recommendation Outperform Date of Last Change 02/10/2014 Current Price (02/05/15) $51.89 Target Price $54.00 (CINF-NASDAQ)
More information2017 SECOND QUARTER RESULTS. Ended June 30, 2017
2017 SECOND QUARTER RESULTS Ended June 30, 2017 Forward Looking Statements Disclaimer This presentation contains statements, including statements about future plans and expectations, which constitute forwardlooking
More informationINNOSPEC REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
INNOSPEC REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS Revenues up 49 percent year over year; Operating up 19 percent Adjusted EBITDA up 52 percent; Adjusted non-gaap EPS up 35 percent Strong
More informationINC Research Q4 & Full Year 2016 Financial Results. February 28, 2017
INC Research Q4 & Full Year 2016 Financial Results February 28, 2017 Forward Looking Statements & Non-GAAP Financial Measures Forward-Looking Statements Except for historical information, all of the statements,
More informationZacks Small-Cap Research
Zacks Small-Cap Research Sponsored Impartial - Comprehensive May 16, 2018 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Net Element Inc. (NETE-NASDAQ)
More informationRockwell Automation Inc.
March 16, 2015 Rockwell Automation Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 07/31/2011 Current Price (03/13/15) $111.52 Target Price $117.00
More informationLow Correlation Strategy Investment update to 31 March 2018
The Low Correlation Strategy (LCS), managed by MLC s Alternative Strategies team, is made up of a range of diversifying alternative strategies, including hedge funds. A distinctive alternative strategy,
More informationAAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC
December 13, 2018 Morning Meeting Note Company Update AAON, Inc. (AAON) Equity Research In Our View, AAON s Outlook For 2019 Is Positive Based On Backlog, Order Trend And Price/Cost; However, We Are Cautious
More informationThird-Quarter 2012 Earnings Presentation
Third-Quarter 2012 Earnings Presentation Ursula Burns Chairman & CEO Luca Maestri Chief Financial Officer October 23, 2012 Forward-Looking Statements This presentation contains "forward-looking statements"
More information(DAKT - - $16.12) 26, 2003 DAKT
Dennis Nielsen denielsen@feltl.com (612) 492-8806 Consumer Products - Durables August 26, 2003 Financial Summary Rev (mil) 2002 2003A 2004E July $40.2 $44.1 $48.9A Oct $41.6 $48.1 $54.8E Jan $30.9 $38.2
More informationPlease see pages 7 and 8 of this publication for important certification and disclosure information.
Industry: Financial Services GICS Sector/ Sub code: Financials Sector / Banks (GIC Code: 40 / Sub code: 4010) Company Summary: On Deck Capital ( ONDK, or the Company) is an online alternative small business
More informationQ Conference Call. November 2, 2018
Q3 2018 Conference Call November 2, 2018 Forward Looking Statements This presentation contains forward-looking information regarding future events or the Company s future financial performance based on
More informationVistaprint N.V. NEUTRAL ZACKS CONSENSUS ESTIMATES (VPRT-NASDAQ) SUMMARY
October 30, 2014 Vistaprint N.V. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/07/2013 Current Price (10/29/14) $55.06 Target Price $58.00 52-Week High
More information